Evidence map›Paper›PMID 38610946›Full record

ArticleCancers2024

Racial Differences in the Detection Rate of Bladder Cancer Using Blue Light Cystoscopy: Insights from a Multicenter Registry.

Seyedeh-Sanam Ladi-Seyedian, Alireza Ghoreifi, Badrinath Konety, Kamal Pohar, Jeffrey M Holzbeierlein, John Taylor, Max Kates, Brian Willard, Jennifer M Taylor, Joseph C Liao and 7 more

Registry-linked trialOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02660645 (Blue Light Cystoscopy With Cysview® Registry), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02660645 recruitingnot on this map

Blue Light Cystoscopy With Cysview® Registry

Typeobservational_patient_registrySponsorPhotocureRan2014 to 2028Enrolled4,400ConditionsBladder CancerArmsHexaminolevulinate hydrochloride (HCL), Karl Storz D-Light C Photodynamic Diagnostic (PDD) system
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 13 institutions in 1 country.

Seyedeh-Sanam Ladi-SeyedianDepartment of Urology, Norris Cancer Center, University of Southern California, Los Angeles, CA 90033, USA.
Alireza GhoreifiDepartment of Urology, Norris Cancer Center, University of Southern California, Los Angeles, CA 90033, USA.ORCID 0000-0002-7368-7240
Badrinath KonetyAllina Health Cancer Institute, Minneapolis, MN 55407, USA.
Kamal PoharDepartment of Urology, Ohio State University, Columbus, OH 43210, USA.
Jeffrey M HolzbeierleinDepartment of Urology, University of Kansas, Kansas City, KS 66045, USA.
John TaylorDepartment of Urology, University of Kansas, Kansas City, KS 66045, USA.
Max KatesThe James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD 21224, USA.
Brian WillardLexington Medical Center, Lexington, SC 29169, USA.
Jennifer M TaylorMichael E. DeBakey VA Medical Center, Baylor College of Medicine, Houston, TX 77030, USA.
Joseph C LiaoVA Palo Alto Health Care System, Palo Alto, CA 94304, USA.
Hristos Z KaimakliotisDepartment of Urology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Sima P PortenDepartment of Urology, University of California San Francisco, San Francisco, CA 94115, USA.
Gary D SteinbergDepartment of Urology, Allina Health Cancer Institute, University of Minnesota, Minneapolis, MN 55407, USA.
Mark D TysonDepartment of Urology, Mayo Clinic Hospital, Phoenix, AZ 85054, USA.
Yair LotanUT Southwestern Medical Center, Dallas, TX 75390, USA.ORCID 0000-0001-5692-2723
Siamak DaneshmandDepartment of Urology, Norris Cancer Center, University of Southern California, Los Angeles, CA 90033, USA.
Blue Light Cystoscopy With Cysview Registry Group
University of Southern California · USMichael E. DeBakey VA Medical Center · USAllina Health · USIndiana University School of MedicineJohns Hopkins University · USLexington Medical Center · USMayo Clinic Hospital · USSouthwestern Medical Center · USThe Ohio State University · USUniversity of California, San Francisco · USUniversity of Kansas · USUniversity of Minnesota · USVA Palo Alto Health Care System · US

Funding

Photocure (Norway) NA
6 · The paper itself

Abstract

The use of blue light cystoscopy (BLC) has been shown to improve bladder tumor detection. However, data demonstrating the efficacy of BLC across different races are limited. Herein, we aim to evaluate heterogeneity in the characteristics of BLC for the detection of malignant lesions among various races. Clinicopathologic information was collected from patients enrolled in the multi-institutional Cysview

Indexed as

bladder cancerblue light cystoscopyracial groupstransurethral resection of bladder

Identifiers

PMID38610946
PMCPMC11011163
OpenAlexW4393142927

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.